1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6B0142C3D76F2EA2D65257808003C4E05
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/internal-brand-communication-strategies-for-educating-employees?opendocument
18
19opendocument
203.84.139.101
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




Products & Services Brand Management and Product Leadership Branding and Identity

Best Practices in Internal Brand Communication: Strategies for Educating Employees

ID: 5110


Features:

8 Info Graphics

13 Data Graphics

90 Metrics

8 Narratives

3 Best Practices


Pages/Slides: 34


Published: Pre-2014


Delivery Format: Online PDF Document


 

License Options:
close

Single User: Authorizes use by the person who places the order or for whom the order was placed.

Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.

Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.




Buy Now

 


  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
Non-members: Click here to review a complimentary excerpt from "Best Practices in Internal Brand Communication: Strategies for Educating Employees"

STUDY OVERVIEW

Disease state education has long been viewed as a critical component of pre-launch communication for a new product, especially for a therapy with a new mechanism of action or in a socially sensitive therapeutic area. While this approach is universally embraced for educating external stakeholders, organizations are less united in their approach to brand and disease state education directed internally to employees.
Leading organizations have found effective education directed at employees regarding new products can have a positive impact on the brand. Best Practices, LLC conducted this research to identify the best practices for communicating disease state or brand information within an organization. The study gives particular attention to communication challenges around products that are first in class or treat socially sensitive conditions.

KEY TOPICS

  • Naming or branding a new medical condition
  • Putting a human face on a medical condition
  • Various tactics for effectively educating employees
  • Using a structured approach for effective communication
  • Communication channels, topics, audience segmentation
  • Insights and lessons learned


SAMPLE METRICS
  • Percentage not using various communication channels
  • Estimated usage level of new communication technologies
  • Ranking of communication topics sent before NDA
  • Ranking of communication topics sent after NDA
  • Ranking of employee segmentation types to optimize communications

SAMPLE KEY FINDING
  • Prevent Leaks: Set up precautions to prevent sensitive information leaks. One pitfall of internal disease state education programs is the leakage of sensitive information. This can occur because employees do not understand – and are not briefed on – the sensitivity of key information elements.


METHODOLOGY

The research employed a data gathering approach that gleaned quantitative data from 32 managers and executives from 22 leading companies in pharmaceutical, biotechnology and medical device industries. In addition, 11 leaders participated in in-depth interviews.


Industries Profiled:
Health Care; Pharmaceutical; Diagnostic; Biotech; Chemical; Medical Device; Consulting


Companies Profiled:
Abbott; Novartis; Actelion; Novo Nordisk; Boehringer Ingelheim; Pfizer; Eli Lilly; ProPharma; Genentech; Roche; GlaxoSmithKline; Sanofi-Aventis; Janssen; Takeda; Vertex; Merck; Sharp & Dohme; Watson; Nektar; Schering-Plough; Xanodyne Pharmaceuticals

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.